|
Status |
Public on Dec 01, 2013 |
Title |
Transcriptional responses of mantle cell lymphoma (MCL) after NIK knockdown |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
MCL lines were treated with or without 100ng/ml doxycycline for 7 days This experiment is designed to see if shRNA-mediated knockdown of NIK downregulates NFKB signaling in MCL lines with mutations in upstream regulators of the alternative pathway (TRAF2 & TRAF3)
|
|
|
Overall design |
MCL cells carrying inducible non-targeting control (NTC) shRNA, NIKshRNA#1 (NIKsh#1), or NIKshRNA#2 (NIKsh#2) were seeded in 6well dishes and treated for 7 days with or without 100ng/ml doxycycline.
|
|
|
Contributor(s) |
Rahal R, Korn JM |
Citation(s) |
24362935 |
|
Submission date |
Nov 15, 2013 |
Last update date |
Mar 25, 2019 |
Contact name |
Joshua M Korn |
E-mail(s) |
joshkorn@gmail.com
|
Organization name |
Novartis
|
Street address |
250 Mass Ave
|
City |
Cambridge |
State/province |
MA |
ZIP/Postal code |
02141 |
Country |
USA |
|
|
Platforms (1) |
GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
Samples (12)
|
|
Relations |
BioProject |
PRJNA228923 |